About Us

Archives






Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference

Posted: October 5, 2021 at 6:08 pm


FOSTER CITY, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, today announced that management will be presenting at the H.C. Wainwright 5th Annual NASH Investor Conference on Tuesday, October 12 at 2:30 p.m. ET.

Here is the original post:
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.